Monday, June 2, 2014

DealBook Column: Do Drug Companies Make Drugs, or Money?

Short-term financial gain, not a sense of nobility, is behind Valeant Pharmaceuticals’ and William Ackman’s deal to buy Allergan.








via NYT > Business Day http://ift.tt/1h1MeZp








via WordPress http://ift.tt/1n6HlxE
Posted by at
Labels: , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)